How much does Telisotuzumab vedotin cost? How to buy?

As of2025year5 months,Telisotuzumab (Telisotuzumab Vedotin)has received accelerated approval from the US FDA for the treatment of patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) with high expression of c-Met. However, the drug is not yet available in mainland China, and patients must purchase it through formal channels if they want to use it.

Currently, Emrelis is mainly obtained through overseas procurement channels. For example, the AxisPharm website offers purchase options for Telisotuzumab vedotin at prices ranging from US$348 to US$1,416 per mg, depending on the dose purchased. In addition, MedChemExpress also provides purchase services for the drug, with prices ranging from US$450 to US$1,800 per mg. It should be noted that these channels are mainly for scientific research institutions and laboratories, and individual patients may need to meet specific conditions for purchase.

In Hong Kong, the DrugsHK website once listed the price of Telisotuzumab Vedotin, but it is currently displayed as “HK$0.00”, which may mean that the drug has not been officially launched or the price has not been disclosed. Therefore, Hong Kong, as a transitional market, may be an option for patients to consider, but caution is still required.

Given thatEmrelis has not yet been marketed in mainland China, when considering using this drug, patients should first consult their attending physician to evaluate its suitability and potential efficacy. At the same time, it is necessary to purchase through formal channels and avoid obtaining drugs through uncertified channels to ensure drug safety and efficacy.

Reference materials:https://www.fda.gov/drugs/resources-information-approved-drugs